GeneDx Holdings Corp. OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax
GeneDx Holdings Corp. (WGS) reported OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax of -$341.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax · last filed 2026-08-03
- GeneDx Holdings Corp. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for the quarter ending 2026-06-30 was -$341.00K.
- GeneDx Holdings Corp. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for the quarter ending 2026-03-31 was -$253.00K, a 437.33% decline year-over-year.
- GeneDx Holdings Corp. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for the quarter ending 2025-12-31 was -$66.00K.
- GeneDx Holdings Corp. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for the quarter ending 2025-09-30 was $190.00K, a 58.61% decline year-over-year.
- GeneDx Holdings Corp. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for fiscal 2025 was $106.00K, a 73.83% decline from fiscal 2024.
- GeneDx Holdings Corp. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for fiscal 2024 was $405.00K, a 4.71% decline from fiscal 2023.
- GeneDx Holdings Corp. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for fiscal 2023 was $425.00K.
- GeneDx Holdings Corp. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for fiscal 2022 was $0.00.
| Period end | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax 3 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax 6 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax 9 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$341.00K 10-Q · filed 2026-08-03 | -$594.00K 10-Q · filed 2026-08-03 | -$660.00K derived: sum of 3 quarters · filed 2026-08-03 | -$470.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$253.00K 10-Q · filed 2026-05-04 | -$319.00K derived: sum of 2 quarters · filed 2026-05-04 | -$129.00K derived: sum of 3 quarters · filed 2026-05-04 | -$222.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | -$66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $124.00K derived: sum of 2 quarters · filed 2026-02-23 | $31.00K derived: sum of 3 quarters · filed 2026-08-03 | $106.00K 10-K · filed 2026-02-23 |
| 2025-09-30 | $190.00K 10-Q · filed 2025-10-28 | $97.00K derived: sum of 2 quarters · filed 2026-08-03 | $172.00K 10-Q · filed 2025-10-28 | $84.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | -$93.00K 10-Q · filed 2026-08-03 | -$18.00K 10-Q · filed 2026-08-03 | -$106.00K derived: sum of 3 quarters · filed 2026-08-03 | $353.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $75.00K 10-Q · filed 2026-05-04 | -$13.00K derived: sum of 2 quarters · filed 2026-05-04 | $446.00K derived: sum of 3 quarters · filed 2026-05-04 | $614.00K derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $371.00K derived: sum of 2 quarters · filed 2026-02-23 | $539.00K derived: sum of 3 quarters · filed 2026-02-23 | $405.00K 10-K · filed 2026-02-23 |
| 2024-09-30 | $459.00K 10-Q · filed 2025-10-28 | $627.00K derived: sum of 2 quarters · filed 2025-10-28 | $493.00K 10-Q · filed 2025-10-28 | $918.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | $168.00K 10-Q · filed 2025-07-29 | $34.00K 10-Q · filed 2025-07-29 | $459.00K derived: sum of 3 quarters · filed 2026-02-23 | $459.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | -$134.00K 10-Q · filed 2025-04-30 | $291.00K derived: sum of 2 quarters · filed 2026-02-23 | $291.00K derived: sum of 3 quarters · filed 2026-02-23 | $291.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $425.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $425.00K derived: sum of 2 quarters · filed 2026-02-23 | $425.00K derived: sum of 3 quarters · filed 2026-02-23 | $425.00K 10-K · filed 2026-02-23 |
| 2023-09-30 | $0.00 10-Q · filed 2024-10-29 | $0.00 derived: sum of 2 quarters · filed 2024-10-29 | $0.00 10-Q · filed 2024-10-29 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-07-30 | $0.00 10-Q · filed 2024-07-30 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-04-29 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |